Does Treatment with Sodium-Glucose Cotransporter-2 Inhibitors Affect Adherence to International Society Criteria for Diabetic Ketoacidosis in Adult Patients with Type 2 Diabetes? A Retrospective Cohort Analysis
Table 2
Demographic information by SGLT2i treatment status.
Variable
SGLT2i ()
Non-SGLT2i ()
value
Demographic information
Sex, (%)
F 42 (44.7%)
F 37 (52.9%)
0.344
M 52 (55.32%)
M 33 (47.1%)
Duration of diabetes (years)
13 (7, 20)
9 (3, 18.5)
0.057
Insulin infusion, (%)
82 (87.2%)
68 (97.1%)
0.026
ICU admission, (%)
17 (18.1%)
20 (28.6%)
0.13
, (%)
27 (35.5%)
16 (31.4%)
0.70
Body mass index (BMI, kg/m2)
28.7 (5.8) (measured in 75/94 patients)
28.6 (7.2) (measured in 53/70 patients)
0.81
Previous DKA/HHS
10 (10.6%)
17 (24.6%)
0.020
Length of stay (days)
4 (2, 8)
5.5 (3, 10)
0.10
Age (years)
62.8 (12.6)
61.7 (17.1)
0.64
HbA1c (%)
9.3 (2.1)
11.7 (2.7)
Baseline eGFR (mL/min)
90 (78, 90)
90 (69, 90)
0.12
Mean (SD), comparisons are by -test. Median (Q1, Q3) where Q1 is the 1st quartile and Q3 is the 3rd quartile. Comparisons are by rank-sum test. Female. Male.
